Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma. Kreuger IZM, Slieker RC, van Groningen T, van Doorn R, et al. J Invest Dermatol 2022 Sep 16. pii: S0022-202X(22)01769.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kreuger IZM, Slieker RC, van Groningen T, van Doorn R, et al. Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma. J Invest Dermatol 2022 Sep 16. pii: S0022-202X(22)01769.
PMID: 36123181